Biotech

All Articles

Lykos 'regrets' not divulging study infractions along with publisher

.Psychopharmacology has pulled three articles concerning midstage scientific trial records examining...

Analysts explore Avidity's DMD win, revealing nuances in records

.Avidity Biosciences amazed clients with period 1/2 records in Duchenne muscle dystrophy (DMD) Frida...

Actinogen's cortisol blocker falls short stage 2 anxiety research study

.Actinogen Medical's cortisol blocker has actually overlooked the primary endpoint of a period 2 res...

Bivictrix makes a decision going personal only method to take ADC in to center

.Antibody-drug conjugates (ADCs) have actually been at the center of lots of a billion-dollar biobuc...

TPG bests up funds to $580M for expenditures across lifestyle scientific researches

.Possession manager TPG, which has actually assisted biotechs like Sionna Rehabs and also Santa Clam...

Merck stops period 3 TIGIT trial in lung cancer cells for impossibility

.Merck &amp Co.'s TIGIT plan has gone through an additional trouble. Months after shuttering a phase...

After a difficult year, Exscientia folds in to Recursion

.After a year defined by pipeline hairstyles, the variation of its CEO and layoffs, Exscientia will ...

Cullinan, after $25M bargain, return bispecific to Port

.Cullinan Therapy was actually blown away good enough with Port BioMed's bispecific invulnerable rea...

A deeper look at Strong Biotech's Ferocious 15

.Within this full week's incident of "The Leading Pipe," our team are actually diving into Strong Bi...

Lilly deals with period 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's celebration commemorating the approval of Alzheimer's...